Vomiting News and Research

RSS
Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.
Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

Baxter launches HYLENEX recombinant for pediatric rehydration at the 2009 ACEP

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

Bristol-Myers Squibb to present new data on BARACLUDE and other compounds at the AASLD 2009

Researchers screen decades-old frozen infant stool samples to detect norovirus

Researchers screen decades-old frozen infant stool samples to detect norovirus

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Presentations on seasonal influenza and H1N1 viruses

Presentations on seasonal influenza and H1N1 viruses

Januvia in combination with metformin or taken alone lowers blood sugar

Januvia in combination with metformin or taken alone lowers blood sugar

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Safety profiles of JANUVIA and JANUMET drugs established through clinical development program

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Morphotek announces preliminary data from Phase II trial of farletuzumab

Morphotek announces preliminary data from Phase II trial of farletuzumab

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulin

FA announces their Second Annual Fellowship Convention dates

FA announces their Second Annual Fellowship Convention dates

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

Merck, QIAGEN to collaborate to increase access to HPV vaccination and HPV DNA testing in developing countries

FDA endorses Covidien's REMS program for EXALGO tablets

FDA endorses Covidien's REMS program for EXALGO tablets

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

King Pharmaceuticals achieves milestone: Announces commercial availability of EMBEDA

Nasdaq Stock Market issues noncompliance letter to A.P. Pharma

Nasdaq Stock Market issues noncompliance letter to A.P. Pharma

Iodinated, Gadolinium based contrast agents do not negatively affect patients

Iodinated, Gadolinium based contrast agents do not negatively affect patients

Pfizer Oncology to present early-stage research of investigational agents for cancer treatment

Pfizer Oncology to present early-stage research of investigational agents for cancer treatment

Millennium's sNDA for VELCADE granted priority review by the FDA

Millennium's sNDA for VELCADE granted priority review by the FDA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.